share_log

HC Wainwright & Co. Maintains Buy on Acurx Pharmaceuticals, Lowers Price Target to $12

Moomoo 24/7 ·  Mar 19 06:32

HC Wainwright & Co. analyst Ed Arce maintains Acurx Pharmaceuticals (NASDAQ:ACXP) with a Buy and lowers the price target from $14 to $12.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment